Acute Endothelial Graft Rejection Following COVID-19 Infection
Overview
Authors
Affiliations
Here, we report a case of acute endothelial graft rejection following coronavirus disease 2019 (COVID-19). A 57-year-old woman who underwent therapeutic penetrating keratoplasty for a perforated infectious corneal ulcer in her right eye developed severe acute respiratory syndrome coronavirus 2 infection, which required intensive care and treatment with steroids. Acute endothelial graft rejection was seen at three weeks postoperatively and managed with high-dose corticosteroids. Despite standard therapy, secondary graft failure was observed. Immune dysregulation associated with COVID-19 may be a significant cause of acute endothelial graft rejection among keratoplasty patients with COVID-19.
Effect of the COVID-19 pandemic on Vogt-Koyanagi-Harada disease.
Muto T, Sakamoto M, Kusuda S, Haruyama Y, Machida S, Imaizumi S Sci Rep. 2024; 14(1):13211.
PMID: 38851824 PMC: 11162482. DOI: 10.1038/s41598-024-63957-1.
COVID and COVID vaccine-related corneal morbidity: A review.
Sidhu N, Vanathi M, Gupta N, Tandon R Indian J Ophthalmol. 2023; 71(12):3595-3599.
PMID: 37991289 PMC: 10788745. DOI: 10.4103/IJO.IJO_765_23.
Alhumaid S, Rabaan A, Dhama K, Yong S, Nainu F, Hajissa K Vaccines (Basel). 2022; 10(8).
PMID: 36016180 PMC: 9412452. DOI: 10.3390/vaccines10081289.
Fujio K, Sung J, Nakatani S, Yamamoto K, Iwagami M, Fujimoto K J Clin Med. 2022; 11(15).
PMID: 35956115 PMC: 9369681. DOI: 10.3390/jcm11154500.